Terms: = Uterine cancer AND HMGA1, MGC4242, 3159, ENSG00000137309, MGC12816, HMGIY, P17096, MGC4854, HMG-R
56 results:
1. [Place of innovative therapies in the management of cervical cancer].
Bello Roufai D
Bull Cancer; 2024 Jan; 111(1):51-61. PubMed ID: 38087730
[TBL] [Abstract] [Full Text] [Related]
2. 3'RNA and whole-genome sequencing of archival uterine leiomyomas reveal a tumor subtype with chromosomal rearrangements affecting either HMGA2, hmga1, or PLAG1.
Jokinen V; Mehine M; Reinikka S; Khamaiseh S; Ahvenainen T; Äyräväinen A; Härkki P; Bützow R; Pasanen A; Vahteristo P
Genes Chromosomes Cancer; 2023 Jan; 62(1):27-38. PubMed ID: 35822448
[TBL] [Abstract] [Full Text] [Related]
3. Hsa_circ_0039569 facilitates the progression of endometrial carcinoma by targeting the miR-197/high mobility group protein A1 axis.
Zhou Y; Pan A; Zhang Y; Li X
Bioengineered; 2022 Feb; 13(2):4212-4225. PubMed ID: 35130798
[TBL] [Abstract] [Full Text] [Related]
4. miR-142-3p simultaneously targets hmga1, HMGA2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human cervical cancer cells.
Sharma P; Yadav P; Jain RP; Bera AK; Karunagaran D
Life Sci; 2022 Feb; 291():120268. PubMed ID: 34973275
[TBL] [Abstract] [Full Text] [Related]
5. KIFC1 promotes aerobic glycolysis in endometrial cancer cells by regulating the c-myc pathway.
Zhou K; Lin J; Dai M; He Y; Xu J; Lin Q
J Bioenerg Biomembr; 2021 Dec; 53(6):703-713. PubMed ID: 34729671
[TBL] [Abstract] [Full Text] [Related]
6. Circular RNA hsa_circ_0000511 Improves Epithelial Mesenchymal Transition of Cervical cancer by Regulating hsa-mir-296-5p/hmga1.
Xie J; Chen Q; Zhou P; Fan W
J Immunol Res; 2021; 2021():9964538. PubMed ID: 34136582
[TBL] [Abstract] [Full Text] [Related]
7. Circ_0067835 sponges miR-324-5p to induce hmga1 expression in endometrial carcinoma cells.
Liu Y; Chang Y; Cai Y
J Cell Mol Med; 2020 Dec; 24(23):13927-13937. PubMed ID: 33169939
[TBL] [Abstract] [Full Text] [Related]
8. SP1-induced lncRNA FOXD3-AS1 contributes to tumorigenesis of cervical cancer by modulating the miR-296-5p/hmga1 pathway.
Ma WG; Shi SM; Chen L; Lou G; Feng XL
J Cell Biochem; 2021 Feb; 122(2):235-248. PubMed ID: 32959937
[TBL] [Abstract] [Full Text] [Related]
9. Stromal p16 Expression Helps Distinguish Atypical Polypoid Adenomyoma From Myoinvasive Endometrioid Carcinoma of the Uterus.
Kihara A; Amano Y; Yoshimoto T; Matsubara D; Fukushima N; Fujiwara H; Niki T
Am J Surg Pathol; 2019 Nov; 43(11):1526-1535. PubMed ID: 31600177
[TBL] [Abstract] [Full Text] [Related]
10. [Efficacy and side effect analysis of paclitaxel liposome for neoadjuvant chemotherapy in locally advanced cervical cancer].
Wang YT; Li B; Li XG; Ma SK; Zhang R; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):588-594. PubMed ID: 31550774
[No Abstract] [Full Text] [Related]
11. Characterizing methylation regulated miRNA in carcinoma of the human uterine cervix.
Varghese VK; Shukla V; Jishnu PV; Kabekkodu SP; Pandey D; Sharan K; Satyamoorthy K
Life Sci; 2019 Sep; 232():116668. PubMed ID: 31326568
[TBL] [Abstract] [Full Text] [Related]
12. Overexpression of
Palumbo Júnior A; de Sousa VPL; Esposito F; De Martino M; Forzati F; Moreira FCB; Simão TA; Nasciutti LE; Fusco A; Ribeiro Pinto LF; Bessa Pereira Chaves C; Meireles Da Costa N
Genes (Basel); 2019 May; 10(5):. PubMed ID: 31096664
[TBL] [Abstract] [Full Text] [Related]
13. Identification of key transcription factors in endometrial cancer by systems bioinformatics analysis.
Song Y; Chen QT; He QQ
J Cell Biochem; 2019 Sep; 120(9):15443-15454. PubMed ID: 31037767
[TBL] [Abstract] [Full Text] [Related]
14. uterine myomas and lower urinary tract dysfunctions: A literature review.
Mourgues J; Villot A; Thubert T; Fauvet R; Pizzoferrato AC
J Gynecol Obstet Hum Reprod; 2019 Nov; 48(9):771-774. PubMed ID: 30905852
[TBL] [Abstract] [Full Text] [Related]
15. Expression of erythropoietin messenger ribonucleic acid in wild-type MED12 uterine leiomyomas under estrogenic influence: new insights into related growth disparities.
Asano R; Asai-Sato M; Matsukuma S; Mizushima T; Taguri M; Yoshihara M; Inada M; Fukui A; Suzuki Y; Miyagi Y; Miyagi E
Fertil Steril; 2019 Jan; 111(1):178-185. PubMed ID: 30554729
[TBL] [Abstract] [Full Text] [Related]
16. hmga1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer.
Fu F; Wang T; Wu Z; Feng Y; Wang W; Zhou S; Ma X; Wang S
Cell Death Dis; 2018 May; 9(6):594. PubMed ID: 29789601
[TBL] [Abstract] [Full Text] [Related]
17. miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells.
Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
Cell Biochem Funct; 2017 Oct; 35(7):464-471. PubMed ID: 29023799
[TBL] [Abstract] [Full Text] [Related]
18. Regulation of NEAT1/miR-214-3p on the growth, migration and invasion of endometrial carcinoma cells.
Wang J; Zhao X; Guo Z; Ma X; Song Y; Guo Y
Arch Gynecol Obstet; 2017 Jun; 295(6):1469-1475. PubMed ID: 28447190
[TBL] [Abstract] [Full Text] [Related]
19. MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells.
Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
Br J Cancer; 2016 Sep; 115(6):741-51. PubMed ID: 27537384
[TBL] [Abstract] [Full Text] [Related]
20. hmga1 facilitates tumor progression through regulating Wnt/β-catenin pathway in endometrial cancer.
Han X; Cao Y; Wang K; Zhu G
Biomed Pharmacother; 2016 Aug; 82():312-8. PubMed ID: 27470368
[TBL] [Abstract] [Full Text] [Related]
[Next]
